Treatment of Arm Lymphedema in Breast Cancer Survivors: A Double-Blind, Randomized Study of Pycnogenol vs. Placebo
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
reduction of arm lymphedema
monthly
No
Paul R Hutson, PharmD
Principal Investigator
University of Wisconsin, Madison
United States: Institutional Review Board
2005-0047
NCT00214032
May 2002
January 2007
Name | Location |
---|---|
University of Wisconsin | Madison,, Wisconsin 53792-5666 |